Catherine Skari
-
Sep- 2026 -7 SeptemberScientific Literature
2026 Update on Clinical Trials in β-Thalassemia
Abstract The therapeutic landscape of β-thalassemia has evolved rapidly over the past decade, shifting from a historical reliance on transfusion…
Read More » -
7 SeptemberScientific Literature
Long-Term Efficacy and Safety Results of Betibeglogene Autotemcel Gene Therapy for Transfusion-Dependent Β-Thalassemia
Abstract Betibeglogene autotemcel (beti-cel) gene therapy for transfusion-dependent β-thalassemia (TDT) involves autologous transplantation of hematopoietic stem and progenitor cells transduced…
Read More » -
7 SeptemberScientific Literature
Exa-cel in Children with Transfusion-Dependent β-Thalassemia or Sickle Cell Disease
Background Exagamglogene autotemcel (exa-cel) is a cell therapy in which autologous CD34+ hematopoietic cells are engineered through ex vivo clustered…
Read More » -
7 SeptemberScientific Literature
Prospective Clinical Validation of Targeted Long-Read Sequencing for Preimplantation Genetic Testing of Α-Thalassaemia
Background: Preimplantation genetic testing for monogenic disorders (PGT-M) can prevent transmission of severe α-thalassaemia, but conventional workflows remain limited by…
Read More » -
7 SeptemberScientific Literature
Optimizing Outcomes snd Accessibility of Matched Sibling Donor Transplant for Transfusion Dependent Thalassemia in LMICs
Abstract Severe thalassemia is a life-threatening condition common in many low- and middle-income countries. While bone marrow transplantation (BMT) offers…
Read More » -
7 SeptemberScientific Literature
Long-Term Survival Rates of Thalassemia Patients Following Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis
Abstract Background: Hematopoietic stem cell transplantation is the sole therapeutic approach that can provide a complete cure for thalassemia. However,…
Read More » -
7 SeptemberScientific Literature
A Descriptive Preanalytical Survey of Procedures Followed for the Screening of Glucose Dysregulation in Thalassemia Centers: Implications for Clinical Practice and Call for Harmonization
Background: Over the last few decades, screening for dysglycemia in transfusion-dependent β-thalassemia patients (β-TDT) using an oral glucose tolerance test…
Read More » -
7 SeptemberScientific Literature
Effects of Vitamin D Deficiency and Supplementation on Myocardial and Hepatic Iron Status and Function in Children with Beta-Thalassemia
Background: This study aimed to evaluate the prevalence of vitamin D deficiency and to assess the effects of vitamin D…
Read More » -
7 SeptemberScientific Literature
Endocrinopathies and Growth in a UK Cohort of Children with Transfusion-Dependent Thalassaemia
Endocrine complications are recognised in transfusion‐dependent thalassaemia (TDT), largely due to iron overload. This is the first study in the…
Read More » -
7 SeptemberScientific Literature
Pancreatic Iron Overload Is Associated With Early QTc Prolongation Before Myocardial Iron Deposition in Transfusion-Dependent Thalassemia
Objectives This cross-sectional study evaluated the 12-lead electrocardiogram (ECG) corrected QT (QTc) interval as an accessible marker for organ-specific iron…
Read More »
